CESANA, Bruno Mario
 Distribuzione geografica
Continente #
NA - Nord America 11.104
EU - Europa 4.498
AS - Asia 2.756
OC - Oceania 19
AF - Africa 17
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.415
Nazione #
US - Stati Uniti d'America 11.083
UA - Ucraina 1.883
CN - Cina 1.804
DE - Germania 835
HK - Hong Kong 506
FI - Finlandia 434
PL - Polonia 310
IT - Italia 295
SG - Singapore 264
IE - Irlanda 259
GB - Regno Unito 185
FR - Francia 96
IN - India 92
SE - Svezia 89
TR - Turchia 57
RU - Federazione Russa 44
BE - Belgio 22
AU - Australia 19
CA - Canada 17
CZ - Repubblica Ceca 16
MU - Mauritius 13
VN - Vietnam 13
TW - Taiwan 8
BR - Brasile 6
EU - Europa 5
IR - Iran 5
GR - Grecia 4
LU - Lussemburgo 4
NL - Olanda 4
CH - Svizzera 3
CL - Cile 3
PE - Perù 3
AR - Argentina 2
BG - Bulgaria 2
EG - Egitto 2
ES - Italia 2
MX - Messico 2
SI - Slovenia 2
AT - Austria 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 18.415
Città #
Fairfield 1.810
Woodbridge 1.705
Jacksonville 1.273
Houston 1.050
Ashburn 776
Ann Arbor 757
Cambridge 720
Seattle 672
Wilmington 653
Nanjing 544
Princeton 507
Hong Kong 506
Warsaw 308
Dublin 259
Chandler 258
Helsinki 186
Nanchang 180
Singapore 152
Beijing 132
Hebei 128
Des Moines 116
Shenyang 112
New York 106
Changsha 101
San Diego 92
Tianjin 85
Jiaxing 83
Jinan 80
Milan 79
Kunming 64
Kocaeli 54
Verona 51
Hangzhou 46
Lanzhou 39
Lancaster 38
Dearborn 37
Shanghai 31
Ningbo 29
Norwalk 25
Zhengzhou 23
Brussels 20
Changchun 19
Guangzhou 19
Brescia 18
Haikou 18
San Francisco 17
Taizhou 14
Boardman 13
Dong Ket 12
London 12
Fuzhou 10
Montichiari 10
Toronto 10
Canberra 9
Olomouc 9
San Mateo 8
Nürnberg 7
Redwood City 7
Los Angeles 6
Munich 6
Pune 6
Taipei 6
Brno 5
Genova 5
Jinhua 5
Melbourne 5
Monmouth Junction 5
Rome 5
Taiyuan 5
Washington 5
Hefei 4
Luxembourg 4
Orange 4
Perugia 4
Sydney 4
Ardabil 3
Athens 3
Augusta 3
Bannewitz 3
Bologna 3
Campofranco 3
Delhi 3
Duncan 3
Florence 3
Indiana 3
Lima 3
Mumbai 3
Ottawa 3
Stuttgart 3
Amsterdam 2
Boston 2
Brivio 2
Brooklyn 2
Charlotte 2
Chicago 2
Feletto Umberto 2
Follonica 2
Frankfurt am Main 2
Freiburg 2
Gallarate 2
Totale 14.247
Nome #
Evidence of cross-reactive immunity to 2009 pandemic influenza A virus in workers seropositive to swine H1N1 influenza viruses circulating in Italy 232
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia. 193
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 190
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 176
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 145
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 143
Gallstone disease and related risk factors in patients with Chron disease. 140
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 135
C-reactive protein levels in the first three hours after acute cerebral infarction. 132
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 130
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 129
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 123
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. 122
Five year time course of celiac disease serology during gluten free diet: results of a community based " CD-Watch" program. 120
Agreement analysis: further statistical insights 120
Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year. 118
A double-blind, placebo-controlled study of Alpidem, a novel anxiolytic of imidazopyridine structure, in chronically anxious patients. 118
A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in "real-world" patients with aortic stenosis and intermediate- to high-risk profile. 116
Serosurvey against H5 and H7 avian influenza viruses in Italian poultry workers. 115
Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study 114
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 113
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 112
Stati emotivi materni in gravidanza e temperamento del bambino nei primi mesi di vita. 111
"Maternal bonding and risk depression in late pregnancy: a survey of Italian nulliparous women" 109
Ventricle-Brain Ratio and Alogia in 19 Young Patients with Chronic Negative and Positive Schizophrenia. 109
Focal adhesion molecules as potential target of lead toxicity in NRK-52E cell line. 107
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? 103
Dementia after First Stroke. 101
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. 101
A 10-year follow-up of a randomized study with methylprednisolone and Chlorambucil in membranous nephropathy. 100
Alpidem, a Novel Anxiolytic Drug. 100
Hepatitis C is more severe in drug users with human immunodeficiency virus infection. 98
A validation study of a new nasogastric polyfunctional catheter 98
Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. 97
A Possible Primary Role for the Kidney in Essential Hypertension. 97
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 97
Language and thought disorder in schizophrenia: brain morphological correlates. 96
Elevation of serum gamma-glutamyltranspeptidase activity is frequent in chronic hepatitis C, and is associated with insulin resistance. 95
CT scan abnormalities and outcome of chronic schizophrenia 95
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 94
Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine. 93
Comparison of measurement methods: An endless application of wrong statistical methods 93
Stroke-Unit and emergency medical service: a 48-month experience in northern Italy 93
Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound. 92
Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. 92
Response to the letter of Hester Den Ruijter and Ruben Coronel regarding the article "the role of n-3 pufas in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy" 91
Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset 91
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 91
Relevance of red cell distribution width (RDW) in the differential diagnosis of microcytic anaemias. 90
Visual anatomical lung CT scan assessment of lung recruitability 90
Variation of therapeutic response in Parkinson's disease: a retrospective study. 89
Experience with a questionnaire administered by emergency medical service for pre-hospital identification of patients with acute stroke 89
Interobserver Reliability Between Neurologists in Training of Parkinson's Disease Rating Scales. A Multicenter Study. 89
T4+ cell depletion as a major risk factor for AIDS-related complex and AIDS. Longitudinal study of 253 HIV-antibody positive heroin addicts from northern Italy. 89
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. 88
Clinical review of 247 Case Records of Spitz Nevus (epithelioid Cell and / or Spindle Cell Nevus). 88
An International Perspective on Assessment of Negative and Positive Symptoms in Schizophrenia. 88
Double-Blind, Controlled Study of the Efficacy and Safety of Alpidem in the Treatment of Anxiety in Schizophrenic In-Patients. 88
Sensations induced by medium and long chain triglycerides: role of gastric tone and hormones. 87
Risk factors for late kidney allograft failure. 87
Renal Transplant Recipients and Chronic Liver Disease: Statistical Evaluation of Predisposing Factors. 87
Natural history of hepatitis C virus infection in adult renal graft recipients 87
Five year time course of celiac disease serology during gluten free diet: Results of a community based " CD-Watch" program 87
Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. 87
Long-term Outcome of Patients with Membranous Nephropathy After Complete Remission of Proteinuria. 87
Antihypertensive Effect of Captopril, Canrenoate Potassium, and Atenolol; Relations with Red Blood Cell Sodium Transport and Renin. 87
Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. 86
Clinical relevance of microvessel density in laryngeal squamous cell carcinomas. 86
Serological markers for coeliac disease: is it time to change? 86
Prognostic Significance of Immunoglobulin Phenotype in B Cell Chronic Lymphocytic Leukemia. 86
Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder 86
Relationship of vascular risk to the progression of Alzheimer disease 86
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. 86
Cisplatin 5-Fluorouracil versus 5-Fluorouracil Alone in Advanced Colorectal Cancer: a Randomized Study. 86
Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide. 85
Increased frequency dependence of specific airway resistance in patients with laryngeal hemiplegia. 85
Late failures in renal transplant recipients under cyclosporine treatment. 85
Clinical Relevance of of Cyclin D1 Protein Overexpression in Laryngeal Squamous Cell Carcinoma. 85
Survival of Children with Cancer in Torino, Italy. 85
Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane 85
Experience with a questionnaire administered by emergency medical service for pre-hospital identification of patients with acute stroke. 84
Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors. 84
P63 in Laryngeal Squamous Cell Carcinoma: Evidence for a Role of TA-p63 Down-Regulation in Tumorigenesis and Lack of Prognostic Implications of p63 Immunoreactivity. 84
No correlation between response and survival in patients with multiple myeloma treated with vincristine, melphalan, cyclophosphamide, and prednisone. 84
A Cisplatinum-Cyclophosphamide Regimen in Advanced Ovarian Cancer: reporting 5-year results. 84
Variability of the haemodynamic responses to laboratory tests employed in assessment of neural cardiovascular regulation in man 84
Gluten intolerance: Gender- and age-related differences in symptoms. 83
Cardiovascular reflexes in Parkinson's disease: long-term effects of levodopa treatment on de novo patients. 83
Preoperative Laparoscopy in Management of Patients with Carcinoma of the Esophagus and of the Esophagogastric Junction. 83
An analysis of the costs of ischemic stroke in an Italian stroke unit. 83
Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous-cell carcinoma 82
Calibration of local systemS with lyophilized calibrant plasmaS improves the interlaboratory variability of the INR in the Italian external quality assessment scheme. 82
Severe Heart Disease in Coeliac Sprue and Inflammatory Bowel Disease: A Common Pathogenesis? 81
Plasma Low-Density Lipoprotein Cholesterol and Bone Mass Densitometry in Postmenopausal Women. 81
Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. 81
Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study. 81
Well being in patients on CAPD and hemodialysis. 81
Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. 81
Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease. 81
Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al. 81
Totale 10.010
Categoria #
all - tutte 76.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.569 0 0 181 762 321 612 554 599 373 574 234 359
2020/20213.325 51 415 43 431 90 420 129 471 574 258 351 92
2021/20221.763 80 307 5 150 21 126 57 128 103 259 129 398
2022/20231.028 276 52 28 35 65 345 1 58 98 6 30 34
2023/20241.306 32 19 37 188 32 140 28 21 518 4 4 283
2024/202532 9 18 5 0 0 0 0 0 0 0 0 0
Totale 18.605